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Abstract
We describe a non-destructive imaging method, named 
contrast-enhanced nanofocus X-ray computed tomography 
(CE-nanoCT), that permits simultaneously imaging 
and quantifying in 3D the (sub)tissue architecture and 
(biochemical) composition of cartilage and bone in small 
animal models at a novel contrast and spatial resolution. 
To demonstrate the potential of this novel methodology, 
a newborn mouse was scanned using CE-nanoCT. This 
allowed simultaneously visualising the bone and cartilage 
structure much like the traditional alcian blue-alizarin red 
skeletal stain. Additionally, it enabled a 3D visualisation at 
such a high spatial image resolution that internal, micro-
scale structures could be digitally dissected and evaluated 
for size, structure and composition. Ex vivo treatment 
with papain, that is known to specifically remove the non-
calcified cartilage layer but keep the calcified cartilage 
intact, proved CE-nanoCT to be applicable to visualise the 
subdivisions within the hyaline cartilage of the articular 
joint of mice. The quantitative power of CE-nanoCT in 
vivo was evaluated using a mouse model for osteoarthritis 
(OA), where OA-like cartilage lesions are induced by 
meniscus destabilisation surgery. The thickness of both 
the non-calcified and calcified cartilage layer in the knee 
joint of such mice was visualised and quantified in 3D 
and compared to unaffected mice. Finally, to show that 
different forms of cartilage and tissue combinations can 
be distinguished using CE-nanoCT, different cartilaginous 
body parts of the mouse were imaged. In conclusion, CE-
nanoCT can provide novel insights in preclinical research 
by quantifying in a non-destructive 3D manner pathological 
differences, in particular in developing mice, newborns or 
adults.
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Introduction
Small animal model quantification is key to understand 
the functionality (Botter et al., 2008) and pathophysiology 
of degenerative joint diseases such as osteoarthritis 
(OA) (Lyons, 2005), as well as other diseases where 
the tight interplay between the cartilaginous and bony 
counterparts has been distorted (e.g. craniosynostosis, 
achondroplasia). Currently, preclinical efficacy of novel 
therapies for bone and cartilage repair in small animal 
models or the skeletal changes during normal or aberrant 
foetal and postnatal development is commonly assessed by 
immunohistochemistry and whole mount skeletal staining 
(Nagy et al., 2003). They have a high discriminative power 
but are destructive, labour intensive, and, in standard 
settings, only provide 2D data. Fluorescence-based 
imaging techniques, such as confocal microscopy (Maye 
et al., 2011), optical projection tomography (OPT) (Sharpe 
et al., 2002) or selective plane illumination microscopy 
(SPIM) (Huisken et al., 2004) are alternatives which are 
commonly used to image gene and protein expression 
during developmental processes. However, for high 
contrast and high resolution imaging these techniques 
require transparent or semi-transparent samples and/or 
are limited to small specimens (~ mm).
 For 3D imaging, EPIC-CT, i.e. equilibrium partitioning 
of an ionic contrast agent via microfocus X-ray computed 
tomography (microCT), has been reported to be highly 
applicable for simultaneous imaging and quantification 
of bone and cartilage structure and composition in pre-
clinical research on small animal models (Kotwal et al., 
2012; Liang et al., 2011; Palmer et al., 2006; Piscaer 
et al., 2008; Xie et al., 2010; Xie et al., 2009). But the 
limited spatial image and/or contrast resolution of EPIC-
CT limits its use in small model organisms such as the 
mouse, where e.g. the thickness of the hyaline cartilage 
can be down to 30 µm (Kotwal et al., 2012), which is 
nearly 10-fold thinner than in the rat and approximately 
50-fold thinner than in man. This inability of EPIC-CT to 
distinguish the architecture and composition of calcified 
versus non-calcified cartilage hampers its use to study 
joint diseases such as OA in small animal models, where 
a loss of sGAGs, fibrillations or finally full-thickness loss 
of non-calcified cartilage and damage of the calcified 
cartilage are all important features of the disease that need 
to be documented.
 In this study, we introduce an improved methodology 
compared to EPIC-CT, named contrast-enhanced 
nanofocus X-ray computed tomography (CE-nanoCT). We 
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have shown that this technique permits for the first time 
imaging the subtissue architecture of cartilage and bone in 
different body parts of mouse models in one single scan, 
and this at a high contrast and spatial image resolution and 
without destructive, labour-intensive sample preparation. 
High contrast differentiation between bone and cartilage, 
as well as other soft tissues, is achieved by the use of an 
anionic contrast agent (i.e. Hexabrix®). When combined 
with the high resolution of nanoCT, this provides the 
necessary spatial image resolution to assess in 3D structure 
and quality of calcified and non-calcified cartilage and 
bone in the course of one single scan. This was proven on 
a mouse newborn, knee joints of mice induced with OA, 
and different mouse body parts.
Materials and Methods
Animal models
Animal experiments were performed in accordance with 
the Belgian legislation under the national authorisation 
number LA1210530 and were approved by the Ethical 
Committee of the Faculty of Biomedical Sciences of the 
University of Leuven.
Mouse newborn
A CD1 newborn pup (E18.5) was sacrificed by suffocation 
with CO2.
Mouse tissue samples
The trachea, patella, paw and several mouse knee joints 
were dissected from adult (Rj:NMRI-Foxn1nu/Foxn1nu) 
mice. The knee joint capsules were dislocated to expose 
the cartilage layers of the tibial plateau and the femoral 
condyles. Knee joints were left untreated or were treated 
ex vivo with papain from papaya latex (Sigma Aldrich 
BVBA, Diegem, Belgium) to enzymatically digest the non-
calcified cartilage layer (treatment: papain 1 % - cysteine 
HCl for 3 d at 60 °C) according to the protocol described 
by Hughes et al. (2005).
 Other knee joints were harvested from mice that were 
sham operated (Sham) or underwent a medial meniscus 
destabilisation procedure (DMM), and were sacrificed 8 
weeks later (Glasson et al., 2007). Again, the knee joint 
capsule was dislocated to expose the cartilage layers of the 
tibial plateau and the femoral condyles. We have worked 
with the nude mouse model to assess the effect of DMM 
on cartilage structure and composition, because it allows 
testing of a cellular therapy in the mouse using human cells 
(on-going work).
 The tissues and knee joints were processed for nanoCT 
imaging after which they were paraffin embedded for 
histological analyses.
Contrast-enhanced nanofocus computed tomography 
(CE-nanoCT)
NanoCT imaging uses a nanofocal spot X-ray tube, 
combined with high geometric magnification, and hence 
differs from conventional medical CT scanning and 
microCT in its ability to resolve details as small as a few 
hundreds of nm in size (Sasov, 2004). The CT system 
applied in this study was a Phoenix NanoTom S (GE 
Sensing & Inspection Technologies GmbH, Wunstorf, 
Germany) with a 180 kV/15 W high-performance 
nanofocus X-ray tube. It was equipped with a tungsten 
target and was operated, for all scans, at a voltage of 60 kV 
and a current of 140 µA. A 1 mm filter of aluminium was 
used. The exposure time was 500 ms and a frame averaging 
of 1 and image skip of 0 was applied, resulting in a scanning 
time of 20 min. Because of the height of the mouse newborn 
being 4-5 times larger than its width and since the highest 
possible spatial image resolution was desired, 5 scans were 
made to capture the full newborn, resulting in a scanning 
time of 100 min. The reconstructed images of the mouse 
newborn had an isotropic voxel size of 4.5 µm. The mouse 
paw and trachea were imaged at an isotropic voxel size of 
3 µm. For the patella and all the knee joints, the isotropic 
voxel size was 2 µm.
 The contrast agent used in this study was an injectable 
solution of ioxaglate meglumine 39.3 % and ioxaglate 
sodium 19.6 % (Hexabrix® 320, Guerbet Nederland BV, 
Gorinchem, The Netherlands). This is a radio-opaque 
dye, which contains ioxaglate, a radio-opaque negatively 
charged ionic iodinated dimer. The negatively charged 
ioxaglate will be locally repulsed by the negative 
fixed charge density of the cartilage, which results 
from the glycosaminoglycans (sGAG) in the cartilage. 
Consequently, ioxaglate accumulation in the cartilage is 
inversely related to the sGAG content. To obtain this, all 
joints and the different body parts were, before imaging, 
immersed for 30 min in a solution of Hexabrix® 320 diluted 
4/5 in PBS, then wrapped in parafilm and stably positioned 
in the nanoCT system. The mouse newborn was, without 
any sample preparation, immersed overnight in a solution 
of Hexabrix® 320 diluted 8/9 in PBS, then positioned in an 
Eppendorf tube that was sealed with parafilm, and stably 
positioned in the nanoCT system for imaging.
3D visualisation and image analysis
For 3D visualisation of the bone and cartilage of the 
mouse newborn and the femora and/or tibiae, Mimics 
(Materialise, Haasrode, Belgium) was applied. To 
quantify the thickness of the non-calcified and calcified 
cartilage layers, the cartilage region was selected using 
CTAn software (Bruker micro-CT, Kontich, Belgium) by 
manually – but consistently – drawing a region of interest 
(ROI) in every 20th cross-section throughout the whole 
tibial plateau. Delineating the total cartilage area (i.e. both 
non-calcified and calcified) was done by readers, blinded 
for the experimental conditions, and was based on (i) the 
difference in grey-scale from the surroundings (i.e. liquid) 
for the non-calcified cartilage, and (ii) the difference in 
structure compared to the subchondral bone and non-
calcified cartilage for the calcified cartilage (i.e. having a 
porous structure). The ROI was interpolated automatically 
for the intermediate cross-sections. By selecting a manually 
chosen global threshold, the non-calcified and calcified 
cartilage were segmented and analysed in 3D by calculating 
the volume, thickness distribution and average thickness. 
The latter two were calculated using a method defined by 
Hildebrand and Ruëgsegger (1997).
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Image validation
The obtained CE-nanoCT images were compared to the 
following standard staining procedures:
Whole mount skeletal staining 
Alcian blue/alizarin red staining of cartilage and bone was 
performed on a cleared newborn (E18.5) as described by 
Nagy et al. (2003).
Histology
After nanoCT imaging, the tissues were processed for 
histology. They were fixed in 10 % formalin, if appropriate 
– decalcified in 4 % formic acid, and embedded in paraffin. 
For the joints, sections of 5 µm were made every 60 µm 
and stained with Safranin-O and counterstained with Fast 
Green, resulting in images where bone stains light blue, 
calcified cartilage stains light red and non-calcified hyaline 
cartilage stains dark red.
Statistical analysis
Statistical analysis was performed using a statistical 
software add-in for Microsoft® Excel® for Windows, 
namely Analyse-it version 2.26 Excel 12+. An unpaired 
Student’s t-test was used to calculate the significance 
level between the Sham and DMM group for the average 
thickness of calcified and non-calcified cartilage. Data was 
significantly different for p-values less than 0.05.
Results
CE-nanoCT allows 3D visualisation and digital 
dissection of a mouse newborn
As a first important and original application, we show 
that a CE-nanoCT scan of a newborn mouse (Fig. 1b) can 
visualise bone and cartilage much like the traditional whole 
mount Alcian Blue-Alizarin Red skeletal stain (Fig. 1a), i.e. 
the red-pink colour represents bone and mineralised tissue 
and blue indicates cartilage. The high-resolution digital 
reconstituted 3D image obtained by CE-nanoCT allows 
easy manipulation and ‘digital dissection’ to evaluate and 
quantify size, structure and composition of internal, micro-
scale structures, e.g. skull (Fig. 1c) or sternum (Fig. 1d). 
The high spatial resolution even allows one to zoom in on 
small internal tissues composed of bony or cartilaginous 
material or a combination thereof. This is exemplified in 
Figs. 1e-h, where (i) the inner ear bones (white arrow in 
Figs. 1e and 1f) become visible after digitally masking 
the cartilaginous tissue, and (ii) typical chondro-osseous 
junctions are shown, such as the hyoid bone (yellow arrow 
in Figs. 1e and 1f) and the transition of the bone and 
cartilaginous part of ribs, revealing the gradual “outside-
in” growth and differentiation of cartilage into bone (Figs. 
1g and 1h).
Fig. 1. (a) Whole mount skeletal stain of a mouse newborn (E18.5) and its (b) 3D reconstruction based on the CE-
nanoCT dataset. In both, the pink colour represents bony and mineralised tissue and blue reveals the cartilage. (c) A 
zoom of the skull of the newborn showing the bone and mineralised tissue. (d) A zoom of (b) showing the sternum 
at the level where the last true ribs fuse (white arrow). (e) The skull of the newborn showing cartilaginous, bone and 
mineralised tissue, where, like the whole mount staining, the internal parts are not visible, and (f) the same image 
as (e), where the cartilage tissue has been digitally omitted revealing the ear bones (white arrow) and hyoid bone 
(yellow arrow). (g) The transition point between cartilage and bone in the chondro-osseous junction of a mouse rib 
(white arrow), and (h) the same image without cartilage tissue, showing the “outside-in” replacement of cartilage 
by bony tissue.
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CE-nanoCT allows discrimination between bone, 
calcified articular cartilage and non-calcified 
articular cartilage in 3D
Fig. 2 shows typical coronal CE-nanoCT sections through a 
femoral condyle and a tibial plateau that were scanned with 
a varying isotropic voxel size, ranging from those that have 
been reported using EPIC-CT (Kotwal et al., 2012; Liang 
et al., 2011; Palmer et al., 2006; Piscaer et al., 2008; Xie 
et al., 2010; Xie et al., 2009) to the highest obtainable with 
CE-nanoCT for the given sample size. The non-calcified 
hyaline cartilage is shown in dark grey, the light grey 
porous layer is the underlying calcified cartilage, and the 
light grey dense structure is the subchondral bone. In the 
10 µm voxel size images of the femoral condyle and the 
tibial plateau (Figs. 2a and 2b), no distinction was possible 
between calcified cartilage and subchondral bone, nor was 
it possible to clearly delineate the non-calcified cartilage. 
Thus, quantification of the thickness of both layers was not 
feasible. In the 5 µm voxel size images (Figs. 2c and 2d), 
one could only distinguish the non-calcified cartilage in 
areas where the thickness of the layer is larger than 15 µm. 
It can be appreciated that only the highest spatial image 
resolution (i.e. isotropic voxel size of 2 µm, Figs. 2e and 
2f) can clearly visualise and discriminate the transition 
between the non-calcified and the calcified cartilage 
as well as the chondro-osseous junction, thus enabling 
quantification of the properties of these layers.
 To confirm the sublineage-specificity of CE-nanoCT, 
femoral condyles treated with papain, specifically removing 
the non-calcified cartilage layer (Hughes et al., 2005), 
were compared to untreated femoral condyles by both 
histological sectioning (Figs. 3a and 3d) and CE-nanoCT 
(Figs. 3b, 3c, 3e and 3f). After papain treatment, the porous 
calcified cartilage layer was still clearly visible on both 
the histological and CE-nanoCT images (highlighted in 
Fig. 3f), whereas the dark-gray non-calcified layer had 
disappeared. This thus confirmed the unprecedented 
discriminative power of CE-nanoCT.
Fig. 2. A representative coronal CE-nanoCT section through a (a, c, e) femoral condyle and (b, d, f) tibial plateau 
scanned with an isotropic voxel size of (a, b) 10 µm, (c, d) 5 µm and (e, f) 2 µm. Within each image, a magnification 
of a part of the chrondro-osseous junction is shown. The non-calcified cartilage appears in dark grey and the light 
grey porous layer is the calcified cartilage. The white to light grey dense structure is the subchondral bone. Scale 
bar = 250 µm.
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CE-nanoCT allows 3D visualisation and 
quantification of the cartilage structure and 
functionality in an in vivo model for osteoarthritis
The broad applicability of CE-nanoCT was also validated 
on adult mouse tibia after in vivo meniscus destabilisation, 
which serves as a model for OA (Glasson et al., 2007). The 
model is characterised by mild inflammation and cartilage 
lesions of various degrees of severities. Figs. 4a and 4b 
both clearly visualise a decrease in sGAG content in the 
non-calcified cartilage layer, whereas in Figs. 4c and 4d 
chondral lesions can be depicted. CE-nanoCT is thus able to 
identify and distinguish between an alteration of cartilage 
composition and cartilage lesions.
 Quantification of the non-calcified and calcified hyaline 
cartilage volume, averaged over the total tibial plateau 
(n = 4 per group), showed local defects with a volume 
of 0.045 ± 0.018 mm3 (i.e. 43.8 % ± 18.9 % loss in non-
calcified cartilage volume). The loss in non-calcified 
cartilage volume ranged from 24.4 % to 64.2 %, which is 
similar to the range mentioned by Glasson et al. (2007). 
Statistical analysis (n = 4) revealed a significant decrease in 
average thickness of the non-calcified cartilage, but leaving 
the underlying calcified cartilage mostly unaffected (Fig. 
5a). This was confirmed in Figs. 5b and 5c, which represent 
a 3D model based on CE-nanoCT images of such a DMM 
mouse (i.e. the mouse with the largest lesion within the 
DMM group: up to 0.061 mm³ or 64 % loss in non-calcified 
cartilage volume to exemplify how severe the lesions 
may be) and a non-treated littermate, and in the averaged 
thickness distribution plots (n = 4) of non-calcified and 
calcified cartilage (Figs. 5d and 5e respectively). It needs 
to be mentioned that, although the angle at which the 3D 
image in Fig. 5b is shown, the impression might be given 
that the cartilage area on the medial side was much larger 
than on the lateral side – this was not the case. The mouse 
that had undergone an in vivo meniscus destabilisation 
(Fig. 5c) displayed, in 3D, a severe lesion within the non-
calcified cartilage on the medial side, which is in line with 
the literature on the pathology in this model (Glasson et 
al., 2007), but so far has lacked quantification.
Fig. 3. (a, d) A representative coronal histological section (Safranin-O/Fast green staining) through the femoral 
condyles, (b, e) the corresponding CE-nanoCT sections, and (c, f) the same CE-nanoCT section with the traced 
regions of interest (i.e. total (non-calcified and calcified) hyaline cartilage) of (a-c) an untreated mouse condyle and 
(d-f) a mouse condyle treated with papain to specifically remove the non-calcified cartilage layer, but preserve the 
calcified cartilage layer. Scale bars = 200 µm.
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CE-nanoCT allows visualising in 3D different forms 
of cartilage and tissue combinations
We validated CE-nanoCT on different forms of cartilage 
within their surrounding tissue by comparing them to 
histological staining. Fig. 6 shows a typical CE-nanoCT 
section through a mouse trachea (Fig. 6b) and patella 
(Fig. 6d), with a corresponding histological section (Figs. 
6a and 6c, respectively). The digital CE-nanoCT section 
of the mouse trachea (Fig. 6b) exemplifies infiltration of 
Hexabrix® into the pericellular matrix of the chondrocytes, 
which allows visualisation of the lacunae. The CE-nanoCT 
image of the mouse patella (Fig. 6d) revealed clearly the 
articular cartilage that slides over the femoral cartilage 
(yellow arrow). On the opposite side (white arrow), a 
highly structured and oriented calcified cartilaginous layer 
is apparent, which serves as the connection to the patellar 
tendon. Besides, tendons, which also contain sGAG, and 
muscle show up in the same grey-scale as the non-calcified 
cartilage (yellow arrow, Fig. 6f; muscle is the feather-like 
structure in the paw of the mouse, white arrow) although 
it appears negative following SafraninO staining (Fig. 6e, 
black arrow).
Discussion
To date, magnetic resonance imaging is, due to its high 
sensitivity for discriminating soft tissues, the standard 
technique for the visualisation and quantification of 
cartilage morphology and functionality (Burstein et al., 
2001; Kuperman, 2000). For bone and mineralised tissue, 
X-ray computed tomography (CT) is the imaging technique 
of choice (Cartmell et al., 2004; Hagenmueller et al., 2007; 
Porter et al., 2007). However, for lab-based research, 
where small animal models are typically used to evaluate 
the efficacy of different therapies for bone and cartilage 
repair or to evaluate cartilage and bone during foetal 
and postnatal development, both techniques suffer from 
shortcomings in the offered spatial image and/or contrast 
resolution. In addition, the use of two different techniques 
to visualise adjacent tissues does not allow for a detailed 
analysis of the structure, function and pathophysiology of 
the chondro-osseous junction, which is for example key 
in understanding the pathogenesis of joint diseases such 
as OA (Glasson et al., 2007).
 Micro-CT has been reported frequently for imaging 
and assessing ex vivo the effect of different types of 
arthritis on the bone structure (Buttgereit et al., 2009; 
Herrak et al., 2004), surface roughness (Seeuws et al., 
2010) and density (Healy et al., 2006). Although this 
technique allows investigation of the effect of arthritis on 
the underlying bone, nothing can be concluded concerning 
cartilage structure and functionality. Additionally, because 
of its limited spatial resolution and field of view, only 
selected parts of the animal (i.e. paw or knee joints) are 
assessed. Micro-CT has also been used to look at skeletal 
Fig. 4. (a, c) A representative histological section and (b, d) the corresponding CE-nanoCT sections through the tibial 
plateau of mice that had undergone in vivo meniscus destabilisation, resulting in a condyle with (a, b) a decrease in 
sGAG content in the non-calcified cartilage layer and (c, d) two lesions. Scale bars = 200 µm.
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development (Liakhovitskaia et al., 2010). Although 
fully in 3D, only the mineralised parts can be imaged and 
analysed.
 As a solution, the combination of Hexabrix®, a 
radio-opaque negatively charged ionic iodinated dimer, 
with micro-CT (i.e. EPIC-CT) has been employed for 
simultaneously imaging bone and cartilage in 3D (Kotwal 
et al., 2012; Liang et al., 2011; Palmer et al., 2006; Piscaer 
et al., 2008; Xie et al., 2010; Xie et al., 2009). For example, 
Piscaer et al. (2008) applied Hexabrix® in vivo to visualise 
and quantify cartilage degeneration in rats. Palmer et al. 
(2006) and Xie et al. (2010) performed similar experiments 
by means of ex vivo micro-CT. However, EPIC-CTs spatial 
image resolution is restricted, and therefore is limited in 
its use for assessment of the mouse model, where the 
thickness of the hyaline cartilage can be down to some tens 
of microns (Kotwal et al., 2012). Indeed, in this study we 
have shown that earlier reported spatial image resolutions 
(Kotwal et al., 2012; Liang et al., 2011; Palmer et al., 
2006; Piscaer et al., 2008; Xie et al., 2010; Xie et al., 2009) 
could not clearly discriminate calcified cartilage from 
subchondral bone. Hence, the total cartilage, which consists 
Fig. 5. (a) Box plots of the average thickness of non-calcified and calcified cartilage on the medial tibial plateau of wild 
type mice (Sham; n = 4) and mice with a destabilised meniscus (DMM; n = 4) [a p = 0.03]. A 3D assembly of a tibia 
of (b) an untreated mouse and (c) a mouse that had undergone an in vivo meniscus destabilisation. The non-calcified 
cartilage layer on the lateral side of the tibia is bright green and transparent, and the calcified cartilage layer in pale 
green. On the medial side, the non-calcified cartilage layer is bright red and transparent, and the calcified cartilage 
layer is pale red. Bone is shown in yellow. The averaged thickness distribution plot of the (d) non-calcified and (e) 
calcified cartilage on the medial tibial plateau of an untreated mouse (Sham; n = 4) and mouse with a destabilised 
meniscus (DMM; n = 4).
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Fig. 6. A coronal histological section (SafO/Fast green staining) and a corresponding CE-nanoCT section through 
the mouse (a, b) trachea, showing lacunae (arrows), (c, d) patella with the articular cartilage (yellow arrow) and on 
the opposite side (black/white arrow) a highly structured and oriented calcified cartilaginous layer, and (e, f) paw, 
where, apart from the articular cartilage (yellow arrow), the muscle (black/white arrow) may be visualised.
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of the calcified and non-calcified zone, was thus likely 
underestimated in these studies. We here have introduced 
an improved non-invasive imaging methodology compared 
to EPIC-CT, i.e. CE-nanoCT, which allows simultaneous 
imaging of cartilage and bone at a novel contrast and spatial 
resolution, and allows discriminating between calcified 
cartilage and subchondral bone; hence all can be visualised 
and quantified in one image dataset.
 Figs. 5d and 5e present averaged distribution plots for 
a Sham operated group and animals that had undergone 
medial meniscus destabilisation (DMM). For the first 
group, where the average non-calcified cartilage thickness 
is well above 15 µm (Fig. 5a), only 2.4 ± 0.3 % of the 
non-calcified cartilage thickness is below 15 µm. For this 
group, the 5 µm voxel size images might be sufficient 
for 3D quantification. However, when severe lesions 
occur, such as in the case of the DMM group, about 14.5 
± 7.7 % of the non-calcified cartilage thickness is below 
15 µm, and about 10.5 ± 5.6 % of the thickness is even 
below 10 µm. In these regions, the limited spatial image 
resolution of EPIC-CT will not suffice to capture important 
differences, and would exclude the analysis of the full 
architecture of calcified and non-calcified cartilage and the 
underlying bone, while the highest attainable resolution of 
CE-nanoCT for these samples allowed quantification of the 
thickness and quality of these different layers. This may 
for example be of importance to understand the transport 
between the subchondral bone and non-calcified cartilage, 
and the early effects of OA (Botter et al., 2008), as well as 
other diseases such as craniosynostosis or achondroplasia. 
An additional argument for the requirement of the high 
contrast and spatial image resolution of CE-nanoCT is 
that OA is a disease that affects the whole joint and is 
characterised by articular cartilage destruction along with 
changes occurring in other joint components, including 
bone, menisci, synovium, ligaments, capsule and muscles. 
All these tissues influence each other and there is still 
discussion on what is the primary cause of OA. Some 
say that the cause of OA might be an inflammation of the 
underlying bone. To assess all different tissues involved, 
it is important to be able to discriminate them. Another 
argument may come from the study of Ea et al. (2011) on 
calcification in the pathology of OA, whereby calcification 
apparently precedes the appearance of cartilage lesions. 
If one wishes to determine such events, high resolution 
and contrast imaging that is able to discriminate calcified 
nodules in non-calcified cartilage, such as CE-nanoCT, is 
required.
 In this study, the thickness of the non-calcified and 
calcified cartilage layers was quantified in 3D by manually 
selecting an ROI delineating the total cartilage area (i.e. 
non-calcified and calcified) in every 20th cross-section 
over the full tibial plateau. The non-calcified cartilage 
was separated from the background (liquid) based on a 
difference in grey-scale. As can be seen in Fig. 4, in regions 
where the sGAG content was low and hence Hexabrix® 
had partially penetrated the non-calcified cartilage, it 
was difficult to distinguish between background and non-
calcified cartilage in an automated way. Hence, we have 
chosen to manually and consistently trace the non-calcified 
cartilage in the cross-sections. The calcified cartilage, 
being porous and thus distinctly different in structure from 
the surrounding tissues (i.e. subchondral bone and non-
calcified cartilage), allows a much more straightforward 
delineation.
 We showed that CE-nanoCT allows for the study of 
the architecture of various types of cartilaginous tissue in 
a small rodent model. By testing this technique on various 
tissues and on mice of different ages, we showed that the 
technology can be implemented widely and thus may be 
used to follow normal and pathological developmental 
processes in mutant animals, and to address various 
pathologies of bone and cartilaginous tissue as well as 
processes of aging. Indeed, the unprecedented 3D skeletal 
reconstruction of a full mouse pup shown in this study 
indicates that CE-nanoCT datasets allow imaging both 
the bone and cartilage of a mouse embryo or newborn 
in one single scan. It enables an easier, faster and more 
detailed 3D quantitative assessment (i.e. sGAG content, 
bone density,…) of the form, size or volume of bone 
and cartilaginous tissue during normal and pathological 
processes, or malformations as a consequence of aberrant 
skeletal development, as compared to state-of-the-art 
skeletal staining. Moreover, internal features can be 
visualised and isolated by digital extraction eliminating 
the need for extensive sample dissection.
 Although EPIC-CT has proven its validity to assess 
preclinical efficacy of novel therapies for bone and cartilage 
repair, Modified Mankin scoring of histological sections is 
still mostly used as the standard evaluation technique due 
to its widespread adoption, ease of use and its similarity 
to scoring systems used for OA in humans (Glasson et 
al., 2010). This method focuses on the structural changes 
observed, such as lesions or fibrillations and losses in 
proteoglycan staining. Immunohistochemistry has a high 
discriminative power but is end stage, destructive, labour 
intensive, and only provides 2D data. Because of the 
high discriminative power of CE-nanoCT, resulting in 
images comparable to the Safranin-O/Fast green-stained 
histological sections typically used for the Modified 
Mankin scoring, we can speculate that the CE-nanoCT 
images can be used with similar accuracy as histological 
sections for Modified Mankin scoring (ongoing work). 
Moreover, CE-nanoCT allows scoring in a 3D setting, 
eliminating the 2D character of the traditional histological 
methodology, which potentially enables capturing 
smaller alterations in cartilage structure. It is tempting 
to speculate that, given the unprecedented discriminative 
and quantitative power of CE-nanoCT at subtissue level, 
it should be feasible to implement the technique to small 
animal models for cartilage diseases other than OA, where 
CE-nanoCT may reveal so far overlooked therapeutic 
efficacies.
 The combination of a contrast agent with the high 
spatial resolution of nanoCT has some limitations. 
Hexabrix® is a negatively charged ionic iodinated dimer, 
and hence will be excluded from tissues that are negatively 
charged. Therefore, not only cartilage but also tendons, 
which also contain sGAG, and muscle will show up in 
the CE-nanoCT images having the same grey-scale as 
the non-calcified cartilage. This is exemplified in Fig. 6 
for the muscle (feather-like structure) in the paw of the 
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mouse, which is devoid of sGAG as it does not stain pink 
upon Safranin/O staining in the corresponding histological 
section. In particular cases, this may generate some 
background, but may – in addition to the chrondro-osseous 
interactions – allow visualisation of the musculo-skeletal 
interaction.
 Moreover, the high X-ray doses needed to obtain the 
required high spatial image and contrast resolution with 
nanoCT do currently not allow in vivo imaging of hyaline 
cartilage subtissues. In addition, Turunen et al. (2011) 
have shown that Hexabrix® may reduce the stiffness of the 
articular cartilage, which is further hypothesised to lead to 
overload-induced cell death. This thus excludes the use of 
the said technique, and in particular the use of Hexabrix® 
as a contrast agent, for in vivo time-lapsed imaging of 
cartilage.
Conclusions
We have implemented a significantly enhanced non-
invasive 3D imaging methodology, i.e. CE-nanoCT, that 
allows simultaneous imaging of cartilage and bone at a 
novel contrast and spatial resolution. By combining the use 
of an anionic contrast agent (i.e. Hexabrix®) with the high 
resolution of nanoCT, CE-nanoCT can reveal differences 
in structure and composition between calcified cartilage, 
non-calcified cartilage and the underlying bone of small 
animal models. By testing this technique on various tissues 
in different body parts and on mice of different ages, we 
showed that the technology can be implemented widely. 
Because of its ability to provide faster, improved and more 
quantitative data on cartilage structure and composition, 
CE-nanoCT has demonstrated potential as an enabling 
technology for preclinical small animal studies especially 
addressing cartilage-related pathologies and therapeutic 
interventions. In addition, the 3D models at the same time 
allow studying morphology and spatial distribution of the 
cartilage.
Acknowledgements
This study was financed by the Agency for Innovation by 
Science and Technology in Flanders (IWT/OZM/090655). 
We are very grateful to G. Vanderlinden, J. Op De Beeck, J. 
Neys and M. Hemelaers for excellent technical assistance. 
We also thank Dr. P. Tylzanowski for performing the 
skeletal staining of the mouse newborn. This work is part 
of Prometheus, the Leuven Research & Development 
Division of Skeletal Tissue Engineering of the KU Leuven: 
www.kuleuven.be/prometheus. We wish to confirm 
that there are no known conflicts of interest associated 
with this publication and there has been no significant 
financial support for this work that could have influenced 
its outcome.
References
 Botter SM, van Osch GJ, Waarsing JH, van der Linden 
JC, Verhaar JA, Pols HA, van Leeuwen JP, Weinans H 
(2008) Cartilage damage pattern in relation to subchondral 
plate thickness in a collagenase-induced model of 
osteoarthritis. Osteoarthritis Cartilage 16: 506-514.
 Burstein D, Velyvis J, Scott KT, Stock KW, Kim YJ, 
Jaramillo D, Boutin RD, Gray ML (2001) Protocol issues 
for delayed Gd(DTPA)(2-)-enhanced MRI (dGEMRIC) 
for clinical evaluation of articular cartilage. Magn Reson 
Med 45: 36-41.
 Buttgereit F, Zhou H, Kalak R, Gaber T, Spies CM, 
Huscher D, Straub RH, Modzelewski J, Dunstan CR, 
Seibel MJ (2009) Transgenic disruption of glucocorticoid 
signaling in mature osteoblasts and osteocytes attenuates 
K/BxN mouse serum-induced arthritis in vivo. Arthritis 
Rheum 60: 1998-2007.
 Cartmell S, Huynh K, Lin A, Nagaraja S, Guldberg R 
(2004) Quantitative microcomputed tomography analysis 
of mineralization within three-dimensional scaffolds in 
vitro. J Biomed Mater Res A 69A: 97-104.
 Ea HK, Nguyen C, Bazin D, Bianchi A, Guicheux J, 
Reboul P, Daudon M, Liote F (2011) Articular cartilage 
calcification in osteoarthritis: insights into crystal-induced 
stress. Arthritis Rheum 63: 10-18.
 Glasson SS, Blanchet TJ, Morris EA (2007) The surgical 
destabilization of the medial meniscus (DMM) model of 
osteoarthritis in the 129/SvEv mouse. Osteoarthritis 
Cartilage 15: 1061-1069.
 Glasson SS, Chambers MG, Van Den Berg WB, 
Little CB (2010) The OARSI histopathology initiative 
– recommendations for histological assessments of 
osteoarthritis in the mouse. Osteoarthritis Cartilage 18 
Suppl 3: S17-23.
 Hagenmueller H, Hofmann S, Kohler T, Merkle HP, 
Kaplan DL, Vunjak-Novakovic G, Mueller R, Meinel 
L (2007) Non-invasive time-lapsed monitoring and 
quantification of engineered bone-like tissue. Ann Biomed 
Eng 35: 1657-1667.
 Healy AM, Izmailova E, Fitzgerald M, Walker R, 
Hattersley M, Silva M, Siebert E, Terkelsen J, Picarella D, 
Pickard MD, LeClair B, Chandra S, Jaffee B (2006) PKC-
theta-deficient mice are protected from Th1-dependent 
antigen-induced arthritis. J Immunol 177: 1886-1893.
 Herrak P, Gortz B, Hayer S, Redlich K, Reiter E, Gasser 
J, Bergmeister H, Kollias G, Smolen JS, Schett G (2004) 
Zoledronic acid protects against local and systemic bone 
loss in tumor necrosis factor-mediated arthritis. Arthritis 
Rheum 50: 2327-2337.
 Hildebrand T, Ruegsegger P (1997) A new method for 
the model-independent assessment of thickness in three-
dimensional images. J Microsc 185: 67-75.
 Hughes LC, Archer CW, ap Gwynn I (2005) The 
ultrastructure of mouse articular cartilage: collagen 
orientation and implications for tissue functionality. A 
polarised light and scanning electron microscope study 
and review. Eur Cell Mater 9: 68-84.
 Huisken J, Swoger J, Del Bene F, Wittbrodt J, Stelzer 
EH (2004) Optical sectioning deep inside live embryos 
by selective plane illumination microscopy. Science 305: 
1007-1009.
 Kotwal N, Li J, Sandy J, Plaas A, Sumner DR (2012) 
Initial application of EPIC-muCT to assess mouse articular 
cartilage morphology and composition: effects of aging and 
treadmill running. Osteoarthritis Cartilage 20: 887-895.
189 www.ecmjournal.org
G Kerckhofs et al.                                                                                     CE-nanoCT reveals cartilage subarchitecture
 Kuperman V (2000) Magnetic Resonance Imaging: 
Physical Principles And Applications, Chapter 1. Academic 
Press, San Diego.
 Liakhovitskaia A, Lana-Elola E, Stamateris E, Rice 
DP, van’t Hof RJ, Medvinsky A (2010) The essential 
requirement for Runx1 in the development of the sternum. 
Dev Biol 340: 539-546.
 Liang G, Vanhouten J, Macica CM (2011) An atypical 
degenerative osteoarthropathy in Hyp mice is characterized 
by a loss in the mineralized zone of articular cartilage. 
Calcif Tissue Int 89: 151-162.
 Lyons SK (2005) Advances in imaging mouse tumour 
models in vivo. J Pathol 205: 194-205.
 Maye P, Fu Y, Butler DL, Chokalingam K, Liu Y, 
Floret J, Stover ML, Wenstrup R, Jiang X, Gooch C, Rowe 
D (2011) Generation and characterization of Col10a1-
mcherry reporter mice. Genesis 49: 410-418.
 Nagy A, Gertsenstein M, Vintersten K, Behringer RR 
(2003) Manipulating the Mouse Embryo: A Laboratory 
Manual, Chapter 16. Cold Spring Harbor Press, New York.
 Palmer AW, Guldberg RE, Levenston ME (2006) 
Analysis of cartilage matrix fixed charge density and 
three-dimensional morphology via contrast-enhanced 
microcomputed tomography. Proc Natl Acad Sci USA 103: 
19255-19260.
 Piscaer TM, Waarsing JH, Kops N, Pavljasevic P, 
Verhaar JAN, van Osch GJVM, Weinans H (2008) In 
vivo imaging of cartilage degeneration using [mu]CT-
arthrography. Osteoarthritis Cartilage 16: 1011-1017.
 Porter BD, Lin ASP, Peister A, Hutmacher D, Guldberg 
RE (2007) Noninvasive image analysis of 3D construct 
mineralization in a perfusion bioreactor. Biomaterials 28: 
2525-2533.
 Sasov A (2004) X-ray nanotomography. In: Bonse U 
(ed) Developments in X-Ray Tomography IV. Proc SPIE 
5535: 201-211.
 Seeuws S, Jacques P, Van Praet J, Drennan M, 
Coudenys J, Decruy T, Deschepper E, Lepescheux L, 
Pujuguet P, Oste L, Vandeghinste N, Brys R, Verbruggen 
G, Elewaut D (2010) A multiparameter approach to monitor 
disease activity in collagen-induced arthritis. Arthritis Res 
Ther 12: R160.
 Sharpe J, Ahlgren U, Perry P, Hill B, Ross A, Hecksher-
Sorensen J, Baldock R, Davidson D (2002) Optical 
projection tomography as a tool for 3D microscopy and 
gene expression studies. Science 296: 541-545.
 Turunen MJ, Toyras J, Lammi MJ, Jurvelin JS, 
Korhonen RK (2011) Hyperosmolaric contrast agents in 
cartilage tomography may expose cartilage to overload-
induced cell death. J Biomech 45: 497-503.
 Xie L, Lin ASP, Levenston ME, Guldberg RE (2009) 
Quantitative assessment of articular cartilage morphology 
via EPIC-mu CT. Osteoarthritis Cartilage 17: 313-320.
 Xie L, Lin ASP, Guldberg RE, Levenston ME 
(2010) Nondestructive assessment of sGAG content and 
distribution in normal and degraded rat articular cartilage 
via EPIC-mu CT. Osteoarthritis Cartilage 18: 65-72.
Discussion with Reviewer
Reviewer II: The main overall issue I have with this work 
is: Do the quantitative measurements you show in the paper 
actually demonstrate the high resolution potential of your 
technique? What about measurements of features <10 µm 
in size? The high resolution you use would allow this. Are 
there no significant changes on this size scale?
Authors: A 10 µm voxel size does not allow the distinction 
between calcified cartilage and subchondral bone in 
the femoral condyle and the tibial plateau of the mice. 
Additionally, it is not possible to clearly delineate the 
non-calcified cartilage. Thus, no quantification of the 
thickness of both layers is feasible. With a 5 µm voxel size, 
the non-calcified cartilage can be distinguished from the 
surrounding, however not when the thickness of the layer 
is smaller than 15 µm. Fig. 5d shows that for the Sham 
group, where the average non-calcified cartilage thickness 
is well above 15 µm (Fig. 5a), only 2.4 ± 0.3 % of the 
non-calcified cartilage thickness is below 15 µm. For this 
group, the 5 µm voxel size images might be sufficient for 
3D quantification. However, when severe lesions occur, 
such as in the case of the DMM group, about 14.5 ± 7.7 % 
of the non-calcified cartilage thickness is below 15 µm, and 
even about 10.5 ± 5.6 % of the thickness is below 10 µm. 
In the latter case, the 5 µm voxel size images will not be 
able to capture important differences, and only the 2 µm 
voxel size attainable with CE-nanoCT is sufficient.
